Home / Compliance actions / 525027

FDA Warning Letter — Bond Drugs

Case 525027 — FEI 3013511021

The FDA took a Warning Letter action against Bond Drugs on May 18, 2017 (Jersey City, NJ). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Bond Drugs
Date
May 18, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Jersey City, NJ (United States)

Facility

Other compliance actions

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.